| Warner Chilcott plc | |
| Industry: | Pharmaceutical industry |
| Fate: | Acquired by Actavis (now Allergan) |
| Founder: | Allen McClay |
| Location: | Rockaway, New Jersey |
Warner Chilcott (formerly Galen) was a company in the pharmaceutical industry based in Rockaway, New Jersey. It was primarily focused on women's healthcare and dermatology. On October 1, 2013, the company was acquired by Actavis (now Allergan).
In 1968, Sir Allen McClay founded Galen, a sales and marketing organization focused on branded pharmaceutical products in the United Kingdom and the Republic of Ireland.[1]
In 1997, the company listed its shares on the London Stock Exchange and the Irish Stock Exchange.[1]
Warner Chilcott was the generic drug business of Warner–Lambert.
In 1996, it was sold to Nale Laboratories P.L.C.[2]
In 2004, the company was acquired by several private equity firms. In 2006, it became a public company via an initial public offering.[3]
In 2000, Galen acquired Warner Chilcott and listed its American depositary receipts on NASDAQ.[1]
In 2004, the company changed its name from Galen to Warner Chilcott.[4]
In August 2004, the company prevailed in a patent case by Teva Pharmaceutical Industries related to Sarafem (Fluoxetine).[5] On May 19, 2006, the company received approval from the Food and Drug Administration for Sarafem.[6]
On October 30, 2009, the company acquired the prescription drug business of Procter & Gamble for $3.1 billion.[7]
On October 1, 2013, the company was acquired by Actavis (now Allergan).[8]